RMORX
Price
$29.15
Change
+$0.03 (+0.10%)
Updated
Jun 22 closing price
Net Assets
71.04M
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

RMORX vs VMGMX

RMORX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
RMORX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMORX is a Buy and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. RMORX (71M). VMGMX pays higher dividends than RMORX: VMGMX (0.62) vs RMORX (0.00). RMORX was incepted earlier than VMGMX: RMORX (10 years) vs VMGMX (15 years). RMORX (1.53) is less costly to investors than VMGMX (0.07). RMORX is a more actively managed with annual turnover of: 88.00 vs. VMGMX (17.00). RMORX has a lower initial minimum investment than VMGMX: RMORX (0) vs VMGMX (3000). RMORX annual gain was more profitable for investors over the last year : 17.09 vs. VMGMX (12.44). VMGMX return over 5 years is better than : 31.82 vs. RMORX (-16.87).
RMORXVMGMXRMORX / VMGMX
Total Expense Ratio0.940.071,343%
Annual Report Gross Expense Ratio1.530.072,186%
Fund Existence10 years15 years-
Gain YTD11.5289.694119%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets71M33.8B0%
Annual Yield % from dividends0.000.62-
Returns for 1 year17.0912.44137%
Returns for 3 years56.3155.17102%
Returns for 5 years-16.8731.82-53%
Returns for 10 yearsN/A212.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEDYX39.04N/A
N/A
Invesco International Value Y
AWYIX63.37N/A
N/A
CIBC Atlas Equity Income Institutional
PBSIX22.73N/A
N/A
Polen 5Perspectives Small Growth Instl
LGMCX25.62-0.17
-0.66%
Loomis Sayles Global Allocation C
LGRCX22.24-0.37
-1.64%
Loomis Sayles Growth C